Guidant Corporation May Cancel $25.4 Billion Johnson & Johnson Acquisition

PHILADELPHIA, Nov 2 (Reuters) - Johnson & Johnson (JNJ.N: Quote, Profile, Research) on Wednesday said it may not complete its $25.4 billion purchase of Guidant Corp. (GDT.N: Quote, Profile, Research) , saying the recall of products at the medical device maker had hurt the value of the company.

Back to news